Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Tissue-engineered liver using 3D-printed silk fibroin scaffolds loaded with stem cells for the treatment of acute liver injury.

Shi X., Wu X., Zhang D., Du F., Hu J., Wang Z.

Animal Study on Face & Skin, published in Regen Biomater (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Regen Biomater (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41282532
PMCID
PMC12639544
DOI
10.1093/rb/rbaf103

Abstract (original English)

Liver tissue engineering offers a promising therapeutic strategy for acute liver injury (ALI). Although traditional biomaterial scaffolds exhibit favorable biocompatibility, they still face limitations in the construction of precise structures and the design of functional properties, making it difficult to fully meet the requirements for the repair of specific organs and tissues. In recent years, 3D-printed silk fibroin (3D-SF) scaffolds have demonstrated broad application prospects in tissue and organ repair owing to their excellent biological properties. In this study, a silk fibroin (SF) solution was used as bioink to successfully fabricate 3D-SF scaffolds with fine microarchitectures and mechanical properties matching those of ALI-affected liver tissue, employing a 4K-resolution micro-nano 3D printer integrated with digital light processing technology. In vitro results demonstrated that adipose-derived mesenchymal stem cells (ADSCs) were able to adhere, proliferate and differentiate into hepatocyte-like cells within the 3D-SF scaffolds under specific inductive factors. In vivo , after transplanting 3D-SF onto the liver surface of ALI mice, liver function was partially improved and hepatic injury was repaired. The combination of ADSCs and 3D-SF (ADSCs@3D-SF) significantly enhanced the efficiency of ALI repair. Pathological analysis revealed the formation of vascular and bili

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research